@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix go: . @prefix ncr: . @prefix ProteinComplex: . @prefix hasAgent: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { ncr:Calcineurin%20Complex a ProteinComplex: . sub:_1 hasAgent: ncr:Calcineurin%20Complex; a go:0016791 . sub:_2 occursIn: species:10116; rdf:object sub:_1; rdf:predicate belv:decreases; rdf:subject schem:Tacrolimus; a rdf:Statement . sub:assertion rdfs:label "a(SCHEM:Tacrolimus) -| phos(complex(NCR:\"Calcineurin Complex\"))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "1.4" . sub:_3 prov:value "In cultured endothelial cells, FK506 enhanced release of tracer adenosine and inhibited uptake of tracer adenosine. It also reduced adenosine kinase activity of the cell membrane fraction. These observations indicate that FK506 inhibits in situ adenosine kinase activity in endothelial cells."; prov:wasQuotedFrom pubmed:11502273 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:11502273; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:29:57.827+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }